Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future trends in aminoglycoside therapy.

S Levin, P H Karakusis

    The American Journal of Medicine
    |June 30, 1986
    PubMed
    Summary

    Aminoglycosides remain crucial for treating serious gram-negative infections, especially with emerging antibiotic resistance. Their continued use in hospital-acquired infections and specific conditions is vital.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Retreatment after excimer laser photorefractive keratectomy. The Melbourne Excimer Laser Group.

    American journal of ophthalmology·1996
    Same author

    Cardiac tamponade without pericardial effusion after blunt chest trauma.

    American heart journal·1996
    Same author

    Near-infrared measurement of cerebral oxygenation. Correlation with electroencephalographic ischemia during ventricular fibrillation.

    Anesthesiology·1995
    Same author

    Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease.

    The Journal of clinical endocrinology and metabolism·1995
    Same author

    Measurements of size distribution and density of a pharmaceutical fat emulsion, using field-programmed sedimentation field-flow fractionation (SdFFF).

    Pharmaceutical research·1995
    Same author

    A toxicologic pathologist's view of apoptosis or I used to call it necrobiosis, but now I'm singing the apoptosis blues.

    Toxicologic pathology·1995

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Microbiology

    Background:

    • Aminoglycosides have been mainstays in treating bacterial infections for 30 years.
    • Concerns about aminoglycoside limitations and new antibiotic development have questioned their future role.
    • Emerging resistance to newer antibiotics necessitates a re-evaluation of established agents.

    Purpose of the Study:

    • To assess the continuing role of aminoglycosides in treating nosocomial infections.
    • To identify factors influencing the future use of aminoglycosides in clinical practice.
    • To highlight the importance of aminoglycosides in specific patient populations and infection types.

    Main Methods:

    • Literature review and analysis of current trends in antibiotic resistance and usage.
    • Evaluation of clinical scenarios where aminoglycosides are essential.
    • Consideration of economic and administrative factors impacting antibiotic selection.

    Main Results:

    • Resistance to new antibiotics is evident, ensuring a continuing role for aminoglycosides.
    • Aminoglycosides will remain important for empiric and synergistic therapy in specific infections.
    • Key applications include hospital-acquired infections in neutropenic patients, enterococcal endocarditis, and Pseudomonas aeruginosa infections.

    Conclusions:

    • Aminoglycosides will continue to be essential in treating complex nosocomial infections.
    • Factors like cost, new drug discovery, and combination therapy will shape their future use.
    • Despite challenges, aminoglycosides offer a valuable therapeutic option against resistant gram-negative pathogens.

    Related Experiment Videos